Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge

Assessing humoral immunogenicity is an interesting challenge for adeno-associated virus (AAV)-based gene therapies. While most people are concerned about how to deal with pre-existing antibodies…